TH29341B - Mixture for the treatment of arthritis - Google Patents
Mixture for the treatment of arthritisInfo
- Publication number
- TH29341B TH29341B TH9601001308A TH9601001308A TH29341B TH 29341 B TH29341 B TH 29341B TH 9601001308 A TH9601001308 A TH 9601001308A TH 9601001308 A TH9601001308 A TH 9601001308A TH 29341 B TH29341 B TH 29341B
- Authority
- TH
- Thailand
- Prior art keywords
- inflammatory
- arthritis
- combination
- quinoline
- continue
- Prior art date
Links
- 206010003246 arthritis Diseases 0.000 title claims abstract 5
- 239000000203 mixture Substances 0.000 title claims 4
- 230000003110 anti-inflammatory effect Effects 0.000 claims abstract 4
- 206010061218 Inflammation Diseases 0.000 claims abstract 3
- 230000004054 inflammatory process Effects 0.000 claims abstract 3
- 239000000730 antalgic agent Substances 0.000 claims abstract 2
- 230000000694 effects Effects 0.000 claims abstract 2
- 229940124641 pain reliever Drugs 0.000 claims 2
- 125000002943 quinolinyl group Chemical class N1=C(C=CC2=CC=CC=C12)* 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 239000002599 prostaglandin synthase inhibitor Substances 0.000 claims 1
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 abstract 4
- 239000003814 drug Substances 0.000 abstract 3
- 229940079593 drug Drugs 0.000 abstract 2
- 239000000126 substance Substances 0.000 abstract 2
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- 230000000202 analgesic effect Effects 0.000 abstract 1
- 229940035676 analgesics Drugs 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 230000007774 longterm Effects 0.000 abstract 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
- 150000003431 steroids Chemical class 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
Abstract
การประดิษฐ์นี้จัดหาสารทางเภสัชกรรม ซึ่งแสดงฤทธิ์ระงับปวดต่อต้านการอักเสบ ที่ออกฤทธิ์ไดรวดเร็ว และคงเรื่อยไป ต่อ ต้านข้ออักเสบเรื้อรัง ซึ่งมีผลข้างเคียงที่มีอยู่ทั่วไป ต่ำ สารทางเภสัชกรรมประกอบด้วยการรวมกันของสารป้องกันโรค/สาร รักษาโรค ชุด ควิโนลีน/ ควิแนโซลีน สำหรับข้ออักเสบ และสาร ระงับปวดต่อต้านการอักเสบที่ออกฤทธิ์ได้ รวดเร็ว ซึ่งรวมถึง (1) สารยับยั้งโซโคลออกซิจีเนส (2) สารระงับปวดที่ศูนย์กลาง (3) สเทอรอยด์ หรือ (4) สารเอนไซม์ต่อต้านการอักเสบ การแสดงผลดีเลิศต่อข้ออักเสบจากระยะแรกของการให้ การมั่นใจ ถึงเสถียรภาพ ของฤทธิ์ต่อต้าน การอักเสบซึ่งมีผลข้างเคียง ที่มีอยู่ทั่วไปต่ำ แม้แต่การให้แบบยาวนาน โดย มีข้อกำหนด ว่า การรวมกันของยา วิธีของการให้ และขนาดใช้ยานั้น เลือก ให้เหมาะสม ตามอาการโรค This invention supplies pharmaceutical substances. Which exhibits analgesic and anti-inflammatory effects That act quickly And continue to continue to fight chronic arthritis Pharmaceutical substances include a combination of prophylactic / therapeutic agents, quinoline / quinoline packets for arthritis and active anti-inflammatory analgesics. These include (1) sorcoloxygenase inhibitors, (2) central analgesics, (3) steroids, or (4) anti-inflammatory enzymes. Excellent results against arthritis from the early stages of ensuring the stability of the anti-inflammatory effect. Inflammation which has side effects Available generally low Even long-term dosing with the stipulation that the combination of drugs Method of giving And the size of the drug is selected to suit the symptoms
Claims (4)
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TH29341A TH29341A (en) | 1998-07-30 |
| TH29341B true TH29341B (en) | 1998-07-30 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2002058620A3 (en) | Pharmaceutical compositions containing a cox-ii inhibitor and a muscle relaxant | |
| EA200100870A1 (en) | COMPOSITION-INHIBITORS OF CYCLOOXYGASE-2 WITH FAST ACCURRENT THERAPEUTIC ACTION | |
| BR0212019A (en) | Dosage forms, methods for treating pain, methods of preparing a dosage form and methods for preventing abuse of a dosage form. | |
| AP1637A (en) | Celecoxib compositions. | |
| BRPI0412557A (en) | pharmaceutical dosage form of cardiovascular events | |
| BR0012136A (en) | Highly selective norepinephrine reabsorption inhibitors and methods of using them | |
| BR9707003A (en) | Compound processes to prepare it for the treatment or prevention of diseases of the endocrine system and for the manufacture of pharmaceutical drugs and the use of a compound | |
| ATE530167T1 (en) | COMBINED DOSAGE FORM CONTAINING A CHOLESTEROL LOWERING AGENT, A RENIN-ANGIOTENSIN INHIBITOR AND ACETYL SALICYLIC ACID | |
| WO2002098370A3 (en) | Methods of administering/dosing cd2 antagonists for the prevention and treatment of autoimmune disorders or inflammatory disorders | |
| CA2370775A1 (en) | Use of a serenoa repens extract for the production of a medicament to treat prostate cancer | |
| WO2001068125A3 (en) | Methods and compositions for the treatment and prevention of erectile dysfunction | |
| BR9911060A (en) | Compositions comprising organic mono- or dinitrate to treat impotence | |
| ATE293451T1 (en) | TREATMENT OF OSTEOARTHRITIS BY ADMINISTRATION OF POLY-N-ACETYL-D-GLUCOSAMINE | |
| ATE191468T1 (en) | METALLOPROTEINASE INHIBITORS | |
| BR0213293A (en) | Use of tfpi or tfpi analog in the treatment of septicemia | |
| CA2433833A1 (en) | Use of flumazenil in developing a drug for the treatment of alcohol dependence | |
| HUP9901360A2 (en) | The use of a cimicifuga racemosa extract | |
| CO5570661A2 (en) | COMBINATIONS THAT INCLUDE COX-2 AND ASPIRINE INHIBITORS | |
| CA2156481A1 (en) | 5-ht2 receptor antagonist compositions useful in treating venous conditions | |
| NO323466B1 (en) | New quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives, processes for their preparation, use thereof in medicaments for the treatment of pain, and pharmaceutical compositions comprising such derivatives | |
| FI951683L (en) | Use of compounds having antiglucocorticoid activity for the preparation of medicaments intended for the prevention or treatment of symptoms associated with spontaneous or triggered withdrawal syndrome from narcotic drugs or mixtures of narcotic drugs, and preparations containing them | |
| WO2005039483A3 (en) | Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity | |
| BR9908885A (en) | Medicinal product for prophylaxis and / or treatment of mastocarcinoma, comprising a steroid aromatase inhibitor | |
| KR970009812A (en) | Activated immunoglobulin | |
| HUP9801628A2 (en) | Therapeutic composition for arthritis |